Efthymios Deliargyris
CIK 1751617 · View on SEC EDGAR ↗
First SEC filing: May 5, 2020 · Latest: May 5, 2020
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 13, 2023 | CTSO | P | 7,894 | — | — | 7,894 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 13, 2023 | CTSO | P | 22,557 | $1.33 | $30,001 | 348,433 Direct | +6.92% | Acquired | -76.3% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 8, 2025 | CTSO | Stock Option (Right to Buy) | Common Stock (95,000) | $1.00 | Aug. 8, 2035 | 95,000 | Acquired |
| Jan. 17, 2025 | CTSO | Series B Right Warrants [F1] | Common Stock (16,233) | — | April 10, 2025 | 16,233 | Acquired |
| Jan. 17, 2025 | CTSO | Series A Right Warrants [F1] | Common Stock (16,233) | — | Feb. 24, 2025 | 16,233 | Acquired |
| Jan. 17, 2025 | CTSO | Subscription Rights (right to buy) | Common Stock (16,233) | $1.00 | Jan. 10, 2025 | 16,233 | Disposed |
| Oct. 4, 2024 | CTSO | Stock Option (Right to Buy) | Common Stock (50,000) | $1.19 | Oct. 4, 2034 | 50,000 | Acquired |
| Oct. 4, 2024 | CTSO | Stock Option (Right to Buy) | Common Stock (100,000) | $1.19 | Oct. 4, 2034 | 100,000 | Acquired |
| April 2, 2024 | CTSO | Stock Option (Right to Buy) | Common Stock (86,000) | $0.96 | April 2, 2034 | 86,000 | Acquired |
| March 29, 2024 | CTSO | Stock Option (Right to Buy) | Common Stock (47,088) | $0.95 | March 29, 2034 | 47,088 | Acquired |
| Dec. 13, 2023 | CTSO | Common Stock Warrant (Right to Buy) | Common Stock (7,894) | $2.00 | Dec. 13, 2028 | 7,894 | Acquired |
| July 7, 2023 | CTSO | Stock Option (right to buy) | Common Stock (40,000) | $3.53 | July 7, 2033 | 40,000 | Acquired |
| July 7, 2023 | CTSO | Stock Option (right to buy) | Common Stock (78,000) | $3.53 | July 7, 2033 | 78,000 | Acquired |
| Aug. 10, 2022 | CTSO | Stock Option (right to buy) | Common Stock (300,000) | $1.95 | Aug. 10, 2032 | 300,000 | Acquired |
| Aug. 10, 2022 | CTSO | Stock Option (right to buy) | Common Stock (74,000) | $1.95 | Aug. 10, 2032 | 74,000 | Acquired |
| April 12, 2021 | CTSO | Stock Option (right to buy) | Common Stock (63,250) | $8.99 | April 12, 2031 | 63,250 | Acquired |
| April 12, 2020 | CTSO | Stock Option (right to buy) | Common Stock (85,500) | $6.59 | April 12, 2030 | 85,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $432,586 | $78,121 | $70,000 | $70,248 | — | — | $12,500 | $663,455 |
| 2024 | $363,336 | $162,985 | $58,255 | $216,366 | — | — | $12,500 | $813,442 |
| 2020 | $253,212 | $101,640 | $131,800 | $331,912 | — | — | $8,654 | $827,218 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.